Home / Market News / $SRTS
fiscal.ai Corporate Catalyst Impact 92/100 ● negative

Sensus Healthcare Reports Third Quarter 2026 Financial Results

Nov 13, 2026, 2:32 PM UTC · Primary ticker $SRTS

Sensus Healthcare reported a wider-than-expected loss per share of $(0.09) for Q3 2026, missing analyst estimates of $(0.06). Quarterly sales also came in at $5 million, indicating a weaker financial performance than anticipated, likely leading to negative market reaction.

Sensus Healthcare announced its third-quarter 2026 financial results, reporting an EPS of $(0.09), which was worse than the analyst consensus of a $(0.06) loss. Additionally, quarterly sales of $5 million likely fell short of expectations, although specific sales estimates were not provided in the filing. This significant earnings miss and potentially disappointing sales figure are direct negative catalysts for Sensus Healthcare, indicating operational challenges or weaker demand. Traders should anticipate a negative short-term reaction in SRTS stock as investors digest the underperformance. The long-term implications will depend on management's outlook and any strategic adjustments, but the immediate outlook is bearish.

$SRTS negative Missed EPS and sales expectations
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.